Clinical trials specialist and UPS-subsidiary Marken has engaged in a wave of acquisitions to boost its presence in central Europe.
Its purchases of Austria’s Der Kurier, Hungary’s Heto and Italy’s HRTL appear to support UPS’s ambition to become a market leader in the clinical trials space.
Marken chief executive Wes Wheeler said: “The acquisition of these companies is an extension of Marken’s growth and satisfies our need for a physical presence in Italy, Austria …
The post Marken expansion pushes UPS to forefront of pharma clinical trials sector appeared first on The Loadstar.
Source: The Loadstar
Be the first to comment on "Marken expansion pushes UPS to forefront of pharma clinical trials sector"